Product identification
Medicine name:
Fasinex 240 mg/ml oral suspension for cattle
Active substance:
- Triclabendazole
Target species:
-
Cattle
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Triclabendazole240.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Oral suspension
Withdrawal period by route of administration:
-
Oral use
-
Cattle
-
Meat and offal56day
-
Milk37dayWhen used in non-lactating animals
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AC01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Available in:
-
Ireland
Package description:
- High density polyethylene bottles of 12.0 litres.
- High density polyethylene bottles of 5.0 litres. (HISTORICAL)
- High density polyethylene bottles of 2.2 litres. (HISTORICAL)
- High density polyethylene bottles of 0.8 litres. (HISTORICAL)
- 0.8 L high density polyethylene bottle with a high density polyethylene induction seal cap and polypropylene spigot cap.
- 2.2 L high density polyethylene bottle with a high density polyethylene induction seal cap and polypropylene spigot cap.
- 5 L high density polyethylene bottle with a high density polyethylene induction seal cap and polypropylene spigot cap.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Manufacturing sites for batch release:
- Elanco France S.A.S.
Authorisation number:
- VPA22020/003/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet